Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) Posted Basic Consolidated EPS Of $1.1429

0

Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) annual basic consolidated EPS was $1.1429 for the period ended 2015-12-31. The basic consolidated EPS was $1.1429 for the quarter ended 2015-12-31.

EPS from continuing operations

Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)’s basic EPS from continuing operations was $1.1429 for the fiscal year 2015-12-31. For the quarter ended 2015-12-31 it stood at $1.1429

EPS contribution from parent

From the parent company Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) posted basic EPS of $1.1429 for the fiscal ended 2015-12-31. For the quarter that ended on 2015-12-31 the figure stood at $1.1429.

Basic net EPS

The Basic net EPS of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) was $1.14 for the period ended 2015-12-31. The figure stood at $1.14 for the quarter that ended 2015-12-31.

Consolidated diluted EPS

The consolidated diluted EPS for the fiscal year 2015-12-31 stood at $1.0856. While the figure for the quarter ended 2015-12-31 stood at $1.0856.

Basic diluted EPS

The diluted EPS from continuing operation of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) stood at $1.0856 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $1.0856

Net diluted EPS

The Net diluted EPS was $1.09 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $1.09.

Diluted EPS from parent

Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) diluted EPS from the parent company for the fiscal 2015-12-31 was $1.0856. The figure for the quarter ended 2015-12-31 was $1.0856

The net basic EPS was $1.14 for fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 was $1.14.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 1 times, 1 visits today)